| Literature DB >> 27849302 |
Imran Khan1, Zafar Tufail1, Saeed Afridi1, Madiha Iqbal1, Tipu Khan1, Abdul Waheed1.
Abstract
Objective: To study the in-hospital outcome of adult patients who had undergone surgical repair for Tetralogy of Fallot.Entities:
Mesh:
Year: 2016 PMID: 27849302 PMCID: PMC5094420 DOI: 10.5935/1678-9741.20160063
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Patient characteristics.
| Characteristic | Number of patients | No patch | Transannular patch | RVOT patch | ||
|---|---|---|---|---|---|---|
| 80 (100%) | 23 (28.75%) | 29 (36.25%) | 28 (35.0%) | |||
| Mean age (range; 12-43) year | 21±0.21 | 14±0.32 | 17±0.41 | 19±0.44 | 0.001 | |
| Gender | Male | 48 (60%) | 15 (65.2%) | 16 (55.2%) | 17 (60.71%) | 0.182 |
| Previous palliation | 15 (18.75%) | 6 (40.0%) | 5 (33.3%) | 4 (57.14%) | 0.035 | |
| Morphology | ||||||
| Main pulmonary artery stenosis | 24 (30.0%) | 7 (30.43%) | 9 (31.03%) | 9 (28.57%) | 0.059 | |
| Right pulmonary artery stenosis | 14 (17.5%) | 3 (13.0%) | 5 (17.8%) | 6 (20.6%) | 0.033 | |
| Left pulmonary artery stenosis | 12 (15%) | 2 (8.6%) | 4 (13.7%) | 6 (20.6%) | 0.002 | |
| Major aortopulmonary collateral arteries | 5 (6.25%) | 1 (4.3%) | 2 (6.8%) | 3 (10.6%) | 0.028 | |
| Right aortic arch | 30 (37.5%) | 7 (30.43%) | 10 (34.48%) | 13 (46.42%) | 0.001 | |
| Aberrant subclavian artery | 3 (3.75%) | 1 (4.34%) | 1 (3.57%) | 1 (3.45%) | 1.457 | |
| Atrial septal defect | 27 (33.75%) | 6 (30.43%) | 10 (34.48%) | 11 (39.28%) | 0.032 | |
| Left superior vena cava | 5 (6.25%) | 1 (4.34%) | 2 (6.8%) | 2 (7.1%) | 0.119 | |
| Patent ductus arteriosus | 6 (7.5%) | 2 (8.6%) | 2 (6.8%) | 2 (7.1%) | 0.456 | |
| Double outlet right ventricle | 3 (3.75%) | 1 (4.34%) | 1 (3.57%) | 1 (3.45%) | 1.457 | |
=one way Anova,
=for chi-square test
Major postoperative complications.
| Characteristic | Number of patients | No patch | Transannular patch | RVOT patch | |
|---|---|---|---|---|---|
| 80 (100%) | 23 (28.75%) | 29 (36.25%) | 28 (35.0%) | ||
| Low cardiac output syndrome | 9 (11.25%) | 2 (8.6%) | 3 (10.34%) | 4 (14.28%) | 0.023 |
| Heart block | 4 (5.0%) | 1 (4.34%) | 2 (6.8%) | 1 (3.57%) | 0.058 |
| Pleural effusion requiring tapping | 3 (3.75%) | 1 (4.34%) | 1 (3.57%) | 1 (3.57%) | 1.457 |
| Atrial arrhythmia | 4 (5%) | 0 | 2 (50%) | 2 (50%) | 1.00 |
| Reoperation for bleeding | 3 (3.8%) | 0 | 2 (6.8%) | 1 (3.45%) | 0.001 |
| Pulmonary regurgitation (moderate to severe) | 20 (25%) | 0 | 0 | 20 (25%) | 0.001 |
| Abbreviations, acronyms & symbols | |
|---|---|
| AVSD | =Atrioventricular septal defect |
| LAD | =Left anterior descending |
| MAPCAS | =Major aortopulmonary collateral arteries |
| PA | =Pulmonary artery |
| PR | =Pulmonary regurgitation |
| RCA | =Right coronary artery |
| RV | =Right ventricular |
| RVOT | =Right ventricular outflow tract |
| TAP | =Transannular patch |
| ToF | =Tetralogy of Fallot |
| VSD | =Ventricular septal defect |
| Authors’ roles & responsibilities | |
|---|---|
| IK | Final manuscript approval |
| ZT | Realization of operations and/or trials; final manuscript approval |
| SA | Realization of operations and/or trials; final manuscript approval |
| MI | Analysis and/or data interpretation; statistical analysis; final manuscript approval |
| TK | Realization of operations and/or trials; final manuscript approval |
| AW | Final manuscript approval |